
|Articles|August 1, 2005
- Volume 0 0
Insomnia Perplexes Sleep Experts
Advertisement
Chronic insomnia remains a mystery,concluded a panel of specialists convenedby the National Institutes ofHealth. The panel did find, however, thatchronic insomnia is a major health problem,and too many individuals are usingunproven therapies, even with treatmentsavailable that are effective. Thepanel's report, "Manifestations andManagement of Chronic Insomnia inAdults" found:
- Cognitive/behavioral therapy iseffective and does not have sideeffects
- New prescription sleep pills workwithout many of the side effectsassociated with older agents knownas benzodiazepines
- The most commonly used treatmentsare alcohol and OTC sedatingantihistamines; alcohol usuallydisrupts quality sleep, and antihistaminescan cause lasting daytimesedation and other cognitive problems
- There is no evidence supporting theeffectiveness of the dietary supplementsmelatonin and valerian tocombat insomnia
The panel recommended a broaderrange of research into insomnia, reportingthat, if researchers understood itsunderlying cause, they could developeffective treatments.
Articles in this issue
almost 21 years ago
CAN YOU READ THESE Rxs?almost 21 years ago
Business Booms for Automated Pharmacyalmost 21 years ago
SureScripts Program Gains Momentumalmost 21 years ago
Alliance Expands Hospital Optionsalmost 21 years ago
Initiative Promotes E-Prescribingalmost 21 years ago
Medical Center Activates SafetyMed RNalmost 21 years ago
Compounding Hotlinealmost 21 years ago
Prostate Health Considerations: The Pharmacist's Rolealmost 21 years ago
Mobile Technology with Stellaraalmost 21 years ago
Cardinal Health Upgrades AutomationAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
2
ADA 2026: Why Some T2D Patients Don't Respond to GLP-1 RAs—And What Pharmacists Should Screen For
3
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
4
New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes
5





































































































































